US Stock MarketDetailed Quotes

TRDA Entrada Therapeutics

Watchlist
  • 10.990
  • -0.340-3.00%
Close Mar 4 16:00 ET
413.16MMarket Cap6.54P/E (TTM)

Entrada Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-129.73%-41.56M
-687.57%-31.61M
0.92%-24.27M
213.51%39.83M
-112.55%-25.52M
249.07%139.8M
85.30%-4.01M
10.88%-24.49M
-94.85%-35.09M
1,068.98%203.4M
Net income from continuing operations
1,081.69%65.63M
111.85%1.13M
-139.57%-14.03M
312.25%55.03M
452.05%23.5M
92.93%-6.69M
61.25%-9.54M
241.07%35.46M
-11.86%-25.93M
69.20%-6.67M
Depreciation and amortization
32.81%3.77M
34.78%992K
12.35%937K
24.66%910K
72.64%934K
49.92%2.84M
39.92%736K
61.63%834K
57.67%730K
38.72%541K
Change In working capital
-187.19%-118.85M
-1,316.42%-35.92M
79.44%-12.82M
-63.14%-18.47M
-124.95%-51.65M
1,326.85%136.32M
149.39%2.95M
-1,025.92%-62.33M
-652.24%-11.32M
12,676.79%207.01M
-Change in receivables
137.39%2.2M
-26.26%-1.08M
495.86%5.07M
2,635.61%69.84M
-1,037.62%-71.64M
---5.88M
---853K
---1.28M
--2.55M
---6.3M
-Change in prepaid assets
-151.46%-4.44M
-123.75%-2.97M
91.39%-1.27M
-143.88%-2.87M
-38.23%2.68M
161.49%8.62M
725.17%12.52M
-55.36%-14.78M
881.03%6.55M
359.82%4.34M
-Change in payables and accrued expense
-113.08%-658K
-90.02%837K
114.60%865K
51.04%-1.01M
-129.00%-1.35M
-28.63%5.03M
3,240.64%8.39M
-248.21%-5.92M
-191.39%-2.07M
767.48%4.64M
-Change in other current assets
2,922.54%12.88M
201.26%3.12M
43.47%2.61M
59.77%4.59M
148.29%2.56M
-87.14%426K
146.70%1.03M
-6.23%1.82M
11.97%2.87M
-619.71%-5.3M
-Change in other current liabilities
23.93%-9.02M
-350.54%-2.11M
20.98%-3.13M
70.72%-1.99M
7.79%-1.8M
-59.20%-11.86M
141.76%841K
-101.63%-3.96M
-249.79%-6.79M
-27.37%-1.95M
-Change in other working capital
-185.59%-119.81M
-77.73%-33.72M
55.60%-16.97M
-503.22%-87.02M
-91.54%17.9M
--139.98M
---18.97M
---38.21M
---14.43M
--211.58M
Cash from discontinued investing activities
Operating cash flow
-129.73%-41.56M
-687.57%-31.61M
0.92%-24.27M
213.51%39.83M
-112.55%-25.52M
249.07%139.8M
85.30%-4.01M
10.88%-24.49M
-94.85%-35.09M
1,068.98%203.4M
Investing cash flow
Cash flow from continuing investing activities
79.91%-27.8M
180.23%53.37M
-2,119.08%-82.93M
78.47%-24.38M
164.65%26.15M
6.90%-138.4M
1.34%19.04M
63.12%-3.74M
-567.52%-113.26M
77.72%-40.44M
Net PPE purchase and sale
43.75%-3.16M
34.94%-635K
55.87%-639K
31.27%-1.05M
49.76%-838K
-94.46%-5.61M
-37.85%-976K
-78.77%-1.45M
-96.39%-1.52M
-180.81%-1.67M
Net investment purchase and sale
81.44%-24.64M
169.74%54M
-3,494.93%-82.29M
79.11%-23.34M
169.59%26.99M
8.91%-132.78M
2.66%20.02M
75.45%-2.29M
-546.94%-111.74M
78.57%-38.78M
Cash from discontinued investing activities
Investing cash flow
79.91%-27.8M
180.23%53.37M
-2,119.08%-82.93M
78.47%-24.38M
164.65%26.15M
6.90%-138.4M
1.34%19.04M
63.12%-3.74M
-567.52%-113.26M
77.72%-40.44M
Financing cash flow
Cash flow from continuing financing activities
389.44%102.96M
103.19%1.4M
-102.99%-11K
22,781.94%101.37M
-98.95%206K
4,291.86%21.04M
92.74%690K
513.33%368K
3,927.27%443K
38,972.00%19.54M
Net common stock issuance
413.26%99.61M
--0
---392K
--100M
--0
--19.41M
--0
--0
--0
--19.41M
Proceeds from stock option exercised by employees
105.89%3.36M
103.19%1.4M
3.53%381K
208.58%1.37M
59.69%206K
240.29%1.63M
92.74%690K
513.33%368K
3,927.27%443K
158.00%129K
Cash from discontinued financing activities
Financing cash flow
389.44%102.96M
103.19%1.4M
-102.99%-11K
22,781.94%101.37M
-98.95%206K
4,291.86%21.04M
92.74%690K
513.33%368K
3,927.27%443K
38,972.00%19.54M
Net cash flow
Beginning cash position
45.71%71.55M
46.87%82M
126.07%189.2M
-68.74%72.39M
45.71%71.55M
-83.13%49.11M
-2.50%55.83M
-11.73%83.69M
161.43%231.6M
-83.13%49.11M
Current changes in cash
49.74%33.61M
47.34%23.16M
-284.78%-107.2M
178.98%116.82M
-99.54%834K
109.28%22.45M
292.79%15.72M
25.81%-27.86M
-2,475.22%-147.91M
190.13%182.49M
End cash Position
46.97%105.16M
46.97%105.16M
46.87%82M
126.07%189.2M
-68.74%72.39M
45.71%71.55M
45.71%71.55M
-2.50%55.83M
-11.73%83.69M
161.43%231.6M
Free cash flow
-133.32%-44.72M
-546.22%-32.24M
3.99%-24.91M
205.94%38.79M
-113.07%-26.36M
238.81%134.19M
82.19%-4.99M
8.31%-25.94M
-94.92%-36.61M
1,034.59%201.73M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -129.73%-41.56M-687.57%-31.61M0.92%-24.27M213.51%39.83M-112.55%-25.52M249.07%139.8M85.30%-4.01M10.88%-24.49M-94.85%-35.09M1,068.98%203.4M
Net income from continuing operations 1,081.69%65.63M111.85%1.13M-139.57%-14.03M312.25%55.03M452.05%23.5M92.93%-6.69M61.25%-9.54M241.07%35.46M-11.86%-25.93M69.20%-6.67M
Depreciation and amortization 32.81%3.77M34.78%992K12.35%937K24.66%910K72.64%934K49.92%2.84M39.92%736K61.63%834K57.67%730K38.72%541K
Change In working capital -187.19%-118.85M-1,316.42%-35.92M79.44%-12.82M-63.14%-18.47M-124.95%-51.65M1,326.85%136.32M149.39%2.95M-1,025.92%-62.33M-652.24%-11.32M12,676.79%207.01M
-Change in receivables 137.39%2.2M-26.26%-1.08M495.86%5.07M2,635.61%69.84M-1,037.62%-71.64M---5.88M---853K---1.28M--2.55M---6.3M
-Change in prepaid assets -151.46%-4.44M-123.75%-2.97M91.39%-1.27M-143.88%-2.87M-38.23%2.68M161.49%8.62M725.17%12.52M-55.36%-14.78M881.03%6.55M359.82%4.34M
-Change in payables and accrued expense -113.08%-658K-90.02%837K114.60%865K51.04%-1.01M-129.00%-1.35M-28.63%5.03M3,240.64%8.39M-248.21%-5.92M-191.39%-2.07M767.48%4.64M
-Change in other current assets 2,922.54%12.88M201.26%3.12M43.47%2.61M59.77%4.59M148.29%2.56M-87.14%426K146.70%1.03M-6.23%1.82M11.97%2.87M-619.71%-5.3M
-Change in other current liabilities 23.93%-9.02M-350.54%-2.11M20.98%-3.13M70.72%-1.99M7.79%-1.8M-59.20%-11.86M141.76%841K-101.63%-3.96M-249.79%-6.79M-27.37%-1.95M
-Change in other working capital -185.59%-119.81M-77.73%-33.72M55.60%-16.97M-503.22%-87.02M-91.54%17.9M--139.98M---18.97M---38.21M---14.43M--211.58M
Cash from discontinued investing activities
Operating cash flow -129.73%-41.56M-687.57%-31.61M0.92%-24.27M213.51%39.83M-112.55%-25.52M249.07%139.8M85.30%-4.01M10.88%-24.49M-94.85%-35.09M1,068.98%203.4M
Investing cash flow
Cash flow from continuing investing activities 79.91%-27.8M180.23%53.37M-2,119.08%-82.93M78.47%-24.38M164.65%26.15M6.90%-138.4M1.34%19.04M63.12%-3.74M-567.52%-113.26M77.72%-40.44M
Net PPE purchase and sale 43.75%-3.16M34.94%-635K55.87%-639K31.27%-1.05M49.76%-838K-94.46%-5.61M-37.85%-976K-78.77%-1.45M-96.39%-1.52M-180.81%-1.67M
Net investment purchase and sale 81.44%-24.64M169.74%54M-3,494.93%-82.29M79.11%-23.34M169.59%26.99M8.91%-132.78M2.66%20.02M75.45%-2.29M-546.94%-111.74M78.57%-38.78M
Cash from discontinued investing activities
Investing cash flow 79.91%-27.8M180.23%53.37M-2,119.08%-82.93M78.47%-24.38M164.65%26.15M6.90%-138.4M1.34%19.04M63.12%-3.74M-567.52%-113.26M77.72%-40.44M
Financing cash flow
Cash flow from continuing financing activities 389.44%102.96M103.19%1.4M-102.99%-11K22,781.94%101.37M-98.95%206K4,291.86%21.04M92.74%690K513.33%368K3,927.27%443K38,972.00%19.54M
Net common stock issuance 413.26%99.61M--0---392K--100M--0--19.41M--0--0--0--19.41M
Proceeds from stock option exercised by employees 105.89%3.36M103.19%1.4M3.53%381K208.58%1.37M59.69%206K240.29%1.63M92.74%690K513.33%368K3,927.27%443K158.00%129K
Cash from discontinued financing activities
Financing cash flow 389.44%102.96M103.19%1.4M-102.99%-11K22,781.94%101.37M-98.95%206K4,291.86%21.04M92.74%690K513.33%368K3,927.27%443K38,972.00%19.54M
Net cash flow
Beginning cash position 45.71%71.55M46.87%82M126.07%189.2M-68.74%72.39M45.71%71.55M-83.13%49.11M-2.50%55.83M-11.73%83.69M161.43%231.6M-83.13%49.11M
Current changes in cash 49.74%33.61M47.34%23.16M-284.78%-107.2M178.98%116.82M-99.54%834K109.28%22.45M292.79%15.72M25.81%-27.86M-2,475.22%-147.91M190.13%182.49M
End cash Position 46.97%105.16M46.97%105.16M46.87%82M126.07%189.2M-68.74%72.39M45.71%71.55M45.71%71.55M-2.50%55.83M-11.73%83.69M161.43%231.6M
Free cash flow -133.32%-44.72M-546.22%-32.24M3.99%-24.91M205.94%38.79M-113.07%-26.36M238.81%134.19M82.19%-4.99M8.31%-25.94M-94.92%-36.61M1,034.59%201.73M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Taiwan Semiconductor
TSM
+4.06%
Advanced Micro Devices
AMD
+2.57%
Alphabet-A
GOOGL
+2.34%
Alphabet-C
GOOG
+2.34%
NVIDIA
NVDA
+1.69%

Unlock the Full List